Tags:DevelopmentDrugHealthHumanPlatform
Summary: NGM Biopharmaceuticals Inc. is focused on the discovery and development of breakthrough therapeutics for metabolic diseases. NGM has devised a novel discovery platform, relying on human clinical and genetic observations, to identify and validate targets that impact the underlying etiology of disease.
Total raised: $51M

Investors 3

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
15.03.2010Series B$51M-NGM Biopha...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
18.06.2013MedImmune ...MedImmune and NGM Biopharmaceu...--cambridgen...
15.03.2010NGM Biopha...NGM Biopharmaceuticals, Inc., ...USA ventu...-finsmes.co...
12.02.2008Life scien...TODAY’S HEADLINES: Metaboli...--venturebea...